Name | N-(6-chloropyridin-3-yl)-3,4-difluorobenzamide |
---|---|
Synonyms |
Benzamide,N-(6-chloro-3-pyridinyl)-3,4-difluoro
ZTZ233 UNII-VU7278D853 |
Description | ICA-27243 is a selective, potent and orally active KCNQ2/Q3 potassium channel opener with an EC50 of 0.38 μM. ICA-27243 is less effective at activating KCNQ4 and KCNQ3/Q5. ICA-27243 has antiepileptic and anticonvulsant effects[1][2]. |
---|---|
Related Catalog | |
Target |
EC50: 0.38 μM (KCNQ2/Q3 potassium channel)[2] |
In Vitro | In SH-SY5Y human neuroblastoma cells, ICA-27243 produces membrane potential hyperpolarization that could be prevented by coadministration with the M-current inhibitors XE-991 and Linopirdine. ICA-27243 enhances both 86Rb+ efflux (EC50 = 0.2 μM) and whole-cell currents in Chinese hamster ovary cells stably expressing heteromultimeric KCNQ2/Q3 channels (EC50 = 0.4 μM). Activation of KCNQ2/Q3 channels is associated with a hyperpolarizing shift of the voltage dependence of channel activation (V1/2 shift of -19 mV at 10 μM)[1]. |
In Vivo | ICA-27243 (1-100 mg/kg; oral administration; male CD-1 mice) has anticonvulsant activity (ED50 of 8.4 mg/kg) in the mouse maximal electroshock epilepsy model[1]. Animal Model: Male CD-1 mice with electroshock assay[1] Dosage: 1-100 mg/kg Administration: Oral administration Result: Produced a dose-dependent increase in the latency to hind limb extension, exhibiting an ED50 value of 8.4 mg/kg. |
References |
Molecular Formula | C12H7ClF2N2O |
---|---|
Molecular Weight | 268.64700 |
Exact Mass | 268.02100 |
PSA | 45.48000 |
LogP | 3.64950 |